SCHEMBL1117832

SCHEMBL1117832

CCn1c([C@]2(NC(=O)OCc3ccccc3)CC[C@H](CO)OC2)nc(C(=O)O)c(O)c1=O

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
PPIA P62937 1/20 0.34
RORC P51449 1/20 0.33
TSHR P16473 2/20 0.33
FSHR P23945 2/20 0.33
ELANE P08246 1/20 0.33
TLR2 O60603 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
CTSK P43235 2/20 0.33
CYP1A2 P05177 1/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSS P25774 1/20 0.33
MAOB P27338 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ENPP2 Q13822 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1117763 0.89 ADORA2A (0.36) ADORA2AADORA1PPIARORCTLR2
SCHEMBL1117837 0.83 CTSB (0.36) ADORA2AADORA1PPIATSHRFSHR
SCHEMBL9901321 0.82 SMN1; SMN2 (0.35) ADORA2AADORA1PPIARORCTSHR
SCHEMBL1117758 0.81 ADORA2A (0.32) ADORA2AADORA1PPIARORCAAK1
SCHEMBL5532804 0.81 HDAC1 (0.43) CYP1A2NPC1RAB9AENPP2
SCHEMBL52518 0.77 RNASEH1 (0.39) ADORA2AADORA1TLR2CTSKNPC1
SCHEMBL63767 0.77 RNASEH1 (0.39) ADORA2AADORA1TLR2CTSKNPC1
SCHEMBL52519 0.77 RNASEH1 (0.39) ADORA2AADORA1TLR2CTSKNPC1
SCHEMBL52517 0.77 RNASEH1 (0.39) ADORA2AADORA1TLR2CTSKNPC1
SCHEMBL87027 0.76 NPC1 (0.36) ADORA2AADORA1RORCCTSKCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2280981-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-02-09 EP disclosed
WO-2009117540-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-24 WO disclosed